Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Defang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Human Vaccines|June 19, 2009
Advances in dengue vaccine developmentKanakatte Raviprakash, Gabriel Defang, Timothy Burgess, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2022
Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2Corey Balinsky, Vihasi Jani, Peifang Sun, et al.
Scientific Reports|February 3, 2019
NK Cells Activated through Antibody-Dependent Cell Cytotoxicity and Armed with Degranulation/IFN-γ Production Suppress Antibody-dependent Enhancement of Dengue Viral InfectionPeifang Sun, Maya Williams, Nishith Nagabhushana, et al.
Acta Tropica|July 30, 2017
Detection of selected arboviral infections in patients with history of persistent fever in PakistanTahir Yaqub, Muhammad Zubair Shabbir, Nadia Mukhtar, et al.
Vaccine|November 26, 2021
T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaquesPeifang Sun, Vihasi Jani, Alison Johnson, et al.
Vaccine|October 9, 2017
Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individualsPeifang Sun, Nancy F Crum-Cianflone, Gabriel Defang, et al.
Vaccine|March 19, 2020
Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primatesAppavu K Sundaram, Daniel Ewing, Maria Blevins, et al.
Pathogens (Basel, Switzerland)|June 2, 2021
Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c MiceAppavu K Sundaram, Daniel Ewing, Zhaodong Liang, et al.
American Journal of Infection Control|January 9, 2019
Nosocomial outbreak of influenza A H3N2 in an inpatient oncology unit related to health care workers presenting to work while illKerry E Wilson, Shannon M Wood, Kurt E Schaecher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adultsNancy F Crum-Cianflone, Lynn E Eberly, Chris Duplessis, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Human Vaccines|June 19, 2009
Advances in dengue vaccine developmentKanakatte Raviprakash, Gabriel Defang, Timothy Burgess, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2022
Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2Corey Balinsky, Vihasi Jani, Peifang Sun, et al.
Scientific Reports|February 3, 2019
NK Cells Activated through Antibody-Dependent Cell Cytotoxicity and Armed with Degranulation/IFN-γ Production Suppress Antibody-dependent Enhancement of Dengue Viral InfectionPeifang Sun, Maya Williams, Nishith Nagabhushana, et al.
Acta Tropica|July 30, 2017
Detection of selected arboviral infections in patients with history of persistent fever in PakistanTahir Yaqub, Muhammad Zubair Shabbir, Nadia Mukhtar, et al.
Vaccine|November 26, 2021
T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaquesPeifang Sun, Vihasi Jani, Alison Johnson, et al.
Vaccine|October 9, 2017
Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individualsPeifang Sun, Nancy F Crum-Cianflone, Gabriel Defang, et al.
Vaccine|March 19, 2020
Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primatesAppavu K Sundaram, Daniel Ewing, Maria Blevins, et al.
Pathogens (Basel, Switzerland)|June 2, 2021
Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c MiceAppavu K Sundaram, Daniel Ewing, Zhaodong Liang, et al.
American Journal of Infection Control|January 9, 2019
Nosocomial outbreak of influenza A H3N2 in an inpatient oncology unit related to health care workers presenting to work while illKerry E Wilson, Shannon M Wood, Kurt E Schaecher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adultsNancy F Crum-Cianflone, Lynn E Eberly, Chris Duplessis, et al.
Pageof 2